Lifeboat Foundation

• In the future, going to the doctor’s office might start to feel different, with you or your insurer paying a monthly fee for routine access to your doctor without paying a copay.
• It’s the model for Iora Health, a startup that works with “sponsors” — mainly employers or private health plans for the elderly (known as Medicare Advantage) — that cover the monthly fee. Iora also built out care teams of nurses and other health professionals that can help the doctors within the practice.
• We spoke with Iora’s CEO Rushika Fernandopulle about how he built a company that’s raised more than $250 million with plans to grow to 50 practices around the US by the end of 2019.
• Fernandopulle is one of Business Insider’s 10 people transforming healthcare.
• Visit BusinessInsider.com for more stories.

Fifteen years ago, Rushika Fernandopulle had a radical idea.

A primary care doctor by training, he had been treating patients in the standard, insurance-backed way. But he started to realize that wasn’t working, and insurance wasn’t covering what he wanted to do for patients.

CRISPR Research Moves Out Of Labs And Into Clinics Around The World : Shots — Health News This could be a crucial year for the powerful gene-editing technique CRISPR as researchers start testing it in patients to treat diseases such as cancer, blindness and sickle cell disease.

Pets in a British animal hospital have been found to be harbouring potentially lethal drug-resistant bugs that could be transferred to owners.

Tests by Public Health England (PHE) revealed three cats a dog were colonised by bacteria able to fend off Linezolid, a “last-resort” antibiotic used to treat superbugs such as MRSA (methicillin-resistant Staphylococcus aureus).

No staff or owners are known to have been taken ill as a result, however the agency last night warned veterinary surgeries to enforce proper cleaning practices after this first discovery of its kind.

Continue reading “Drug-resistant bugs discovered in animal hospital prompts health warning” »

Drug-resistant fungi are appearing around the globe, and some are known to cause illness in humans.

The number of new measles cases in the United States rose again this month, the Centers for Disease Control and Prevention said on Monday, bringing the total number to 555 in 2019. This year’s outbreak is on course to be the worst since the country eliminated measles as an endemic disease in 2000.

Health authorities reported 90 additional cases as of April 11, with outbreaks in New York, Washington, California, New Jersey and Michigan, up from 78 the week before. Those cases were largely linked to travelers returning from countries seeing outbreaks of their own, including Israel, Ukraine and the Philippines.

The disease then spread through populations in which large numbers of people are unvaccinated, the C.D.C. said.

Continue reading “90 New Cases of Measles Reported in U.S. as Outbreak Continues Record Pace” »

;-;

The rise of Candida auris embodies a serious and growing public health threat: drug-resistant germs.

In fact, according to IRENA’s new report, the most cost-effective strategy to achieve a “climate-safe future” — keeping global warming below 2 degrees Celsius (3.6 degrees Fahrenheit) — is an accelerated energy transition to renewables and energy efficiency coupled with electrification of key sectors like transportation.

This Renewable Energy Roadmap (REmap) scenario “would also save the global economy up to USD 160 trillion cumulatively over the next 30 years in avoided health costs, energy subsidies and climate damages.”

At the same time, IRENA reports, “every dollar spent on energy transition would pay off up to seven times.”

Continue reading “Global economy would save up to $160 trillion” »

Researchers have identified ketamine-induced brain-related changes that are responsible for maintaining the remission of behaviors related to depression in mice—findings that may help researchers develop interventions that promote lasting remission of depression in humans. The study, funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, appears in the journal Science.

Major depression is one of the most common mental disorders in the United States, with approximately 17.3 million adults experienced a major depressive episode in 2017. However, many of the neural changes underlying the transitions between active depression, remission, and depression re-occurrence remain unknown. Ketamine, a fast-acting antidepressant which relieves depressive symptoms in hours instead of weeks or longer, provides an opportunity for researchers to investigate the short- and long-term biological changes underlying these transitions.

“Ketamine is a potentially transformative treatment for depression, but one of the major challenges associated with this drug is sustaining recovery after the initial treatment,” said study author Conor Liston, M.D., Ph.D., of Weill Cornell Medicine, New York City.

Continue reading “Ketamine reverses neural changes underlying depression-related behaviors in mice” »